C07B63/00

PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)-PYRROLIDIN-2-YL]IMIDAZO[1,5-a]-PYRAZIN-1-YL}N-(PYRIDIN-2-YL)-BENZAMIDE

The present disclosure relates, in general, to improved processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)-benzamide, particularly large-scale processes for manufacturing 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide and intermediates used in such processes.

MEMBRANES AND METHOD FOR REMOVING TRACE METALS

The disclosure provides certain porous polymeric membranes, coated with cross-linked polymerized monomers, comprising monomers having a charge when immersed in an organic liquid. The membranes of the disclosure are useful in removing trace amounts of metallic impurities thereby providing ultra-pure organic liquids.

MEMBRANES AND METHOD FOR REMOVING TRACE METALS

The disclosure provides certain porous polymeric membranes, coated with cross-linked polymerized monomers, comprising monomers having a charge when immersed in an organic liquid. The membranes of the disclosure are useful in removing trace amounts of metallic impurities thereby providing ultra-pure organic liquids.

Drug crystallization under microgravity conditions

Disclosed is a method for crystallizing molecules having a molecular weight equal to or lower than about 500 Dalton in a gravity below about 0.01 g to about 0.000001 g as well as to crystalline molecules having a molecular weight equal to, or lower than, about 500 Dalton, prepared under microgravity conditions.

Drug crystallization under microgravity conditions

Disclosed is a method for crystallizing molecules having a molecular weight equal to or lower than about 500 Dalton in a gravity below about 0.01 g to about 0.000001 g as well as to crystalline molecules having a molecular weight equal to, or lower than, about 500 Dalton, prepared under microgravity conditions.

Low Halide Lanthanum Precursors For Vapor Deposition

Lanthanide compounds for vapor deposition having ≤50.0 ppm, ≤30.0 ppm, or ≤10.0 ppm of all halide impurity combined is provided. The purification systems and methods are also provided.

CANNABIS EXTRACTS
20210355056 · 2021-11-18 ·

A method is provided for removing THC from raw Cannabis oil. Additionally, new compositions of Cannabis oil are provided. Further, a new method of obtaining a substantially pure cannabinoid is provided

CANNABIS EXTRACTS
20210355056 · 2021-11-18 ·

A method is provided for removing THC from raw Cannabis oil. Additionally, new compositions of Cannabis oil are provided. Further, a new method of obtaining a substantially pure cannabinoid is provided

An improved process to increase the performance on filtrate extention

This invention is related to an improvement in the process of filtrate extension of a reaction where at least a set of filtrates of a set of reaction are mixed together to form for a filtrate extension thereby the reaction yields higher order chemical auxiliaries and the reaction is observed that either as convergent or divergent pathway substrate reacts to give qualitative products quantitative, conversions and very less in numbers. Among qualitative conversion reaction filtrate takes pivotal role in synthesizing chemical auxiliaries.

An improved process to increase the performance on filtrate extention

This invention is related to an improvement in the process of filtrate extension of a reaction where at least a set of filtrates of a set of reaction are mixed together to form for a filtrate extension thereby the reaction yields higher order chemical auxiliaries and the reaction is observed that either as convergent or divergent pathway substrate reacts to give qualitative products quantitative, conversions and very less in numbers. Among qualitative conversion reaction filtrate takes pivotal role in synthesizing chemical auxiliaries.